Your browser doesn't support javascript.
loading
Radiation Therapies in Cancer.
Tariq, Muhammad Rizwan; Ali, Shinawar Waseem; Fatima, Noor; Jabeen, Aqsa; Qazi, Asma Saleem; Hameed, Amna; Safdar, Waseem.
Afiliação
  • Tariq MR; Department of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan. Rizwan.foodsciences@pu.edu.pk.
  • Ali SW; Department of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan.
  • Fatima N; Department of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan.
  • Jabeen A; Department of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan.
  • Qazi AS; Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.
  • Hameed A; Department of Diet and Nutritional Sciences, Ibadat International University, Islamabad, Pakistan.
  • Safdar W; Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.
Cancer Treat Res ; 185: 59-77, 2023.
Article em En | MEDLINE | ID: mdl-37306904
ABSTRACT
A crucial element of cancer treatment is radiation therapy that is used to destroy tumors and cancer cells through radiation. Another essential component is immunotherapy that helps immune system to combat cancer. The combination of both radiation therapy and immunotherapy is being focused recently for the treatment of many tumors. Chemotherapy includes the use of some chemical agent to control the growth of cancer, whereas irradiation involves the use of radiations of high energy to kill cancer cells. The union of both became the strongest practice in cancer treatment techniques. Specific chemotherapies are combined with radiation in the treatment of cancer after proper preclinical assessment of their effectiveness. Some classes of compounds include platinum-based drugs, antimicrotubules, antimetabolites (5-Fluorouracil, Capecitabine, Gemcitabine, Pemetrexed), topoisomerase I inhibitors, alkylating agents (Temozolomide), and other agents (Mitomycin-C, Hypoxic Sensitizers, Nimorazole).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article